Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-10-07

FDA Approved: LANSOPRAZOLE, AMOXICILLIN, CLARITHROMYCIN — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved a new generic triple-therapy combination of lansoprazole, amoxicillin, and clarithromycin (Original Application) from Rising Pharma Holdings, Inc.,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lansoprazole, Amoxicillin, Clarithromycin (Lansoprazole; Amoxicillin; Clarithromycin)

Snippet

ORIG AP for LANSOPRAZOLE, AMOXICILLIN, CLARITHROMYCIN (LANSOPRAZOLE, AMOXICILLIN, CLARITHROMYCIN)